China’s First Ebola Vaccine Approved For Clinical Trials

2014.12.19

December 18, 2014

The Chinese Academy of Military Medical Sciences (AMMS) announced today that an Ebola vaccine (jointly developed by its Bioengineering Institute and Tianjin Cansino Biotechnology Inc.) has been approved for clinical trials.

CanSino Biotechnology Successfully Passed EU GMP Audit

CanSinotech submitted CTA of “Diphtheria and Tetanus Toxoids and Component Pertussis Vaccine Adsorbed” to CFDA